Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,540
+40 (0.32%)
At close: Dec 5, 2025

Daewon Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-16,03714,21023,91731,9446,98917,640
Upgrade
Depreciation & Amortization
22,41720,09517,56119,36817,80515,674
Upgrade
Loss (Gain) From Sale of Assets
220.76-25.42-149.95-45.710.86-2.34
Upgrade
Asset Writedown & Restructuring Costs
3,0134,6714,5972,1541,111715.77
Upgrade
Loss (Gain) From Sale of Investments
1,2471,14961.5752.76870.39-1,990
Upgrade
Loss (Gain) on Equity Investments
-1,084-704.2-509.42-860.08-382.62-517.27
Upgrade
Provision & Write-off of Bad Debts
-35.91-204.13230.88887.59-250.26-171.71
Upgrade
Other Operating Activities
7,80417,84010,63813,24013,0547,952
Upgrade
Change in Accounts Receivable
-4,968-2,504-7,949-11,075-11,2783,819
Upgrade
Change in Inventory
7,520-6,642-15,837-23,989-4,075-13,944
Upgrade
Change in Accounts Payable
732.661,041938.612,107-1,4451,559
Upgrade
Change in Income Taxes
3.213.21-2.035.05-0.320.49
Upgrade
Change in Other Net Operating Assets
21,821-18,89418,239-8,07514.07-5,784
Upgrade
Operating Cash Flow
42,85430,03551,73426,41322,41324,951
Upgrade
Operating Cash Flow Growth
78.75%-41.94%95.86%17.85%-10.17%-19.43%
Upgrade
Capital Expenditures
-25,502-34,864-12,289-8,009-4,104-11,346
Upgrade
Sale of Property, Plant & Equipment
714.99778.66204.25504.445.1642.79
Upgrade
Cash Acquisitions
-7.62-7.62---14,602-
Upgrade
Sale (Purchase) of Intangibles
-17,655-18,218-8,322-5,357-7,603-4,038
Upgrade
Investment in Securities
-8,532-12,380-893.53-9,055-16,256-33.31
Upgrade
Other Investing Activities
23,38021,020-47,3311,520562.08556.22
Upgrade
Investing Cash Flow
-27,304-42,975-68,267-20,775-41,615-14,893
Upgrade
Short-Term Debt Issued
-60,42120,08130027,069-
Upgrade
Long-Term Debt Issued
-42,00022,0003,35245,920-
Upgrade
Total Debt Issued
60,527102,42142,0813,65272,989-
Upgrade
Short-Term Debt Repaid
--45,000-234.39-468.76-10,063-
Upgrade
Long-Term Debt Repaid
--42,958-10,666-10,062-9,479-1,228
Upgrade
Total Debt Repaid
-38,978-87,958-10,900-10,530-19,541-1,228
Upgrade
Net Debt Issued (Repaid)
21,54814,46331,181-6,87853,448-1,228
Upgrade
Issuance of Common Stock
--106.64-210.31-
Upgrade
Repurchase of Common Stock
----6,171-85.84-5,062
Upgrade
Dividends Paid
-6,430-6,359-7,340-4,120-3,140-5,035
Upgrade
Other Financing Activities
-6,838-8,402-4,434-3,241-1,906-1,260
Upgrade
Financing Cash Flow
8,281-297.8119,513-20,41148,527-12,584
Upgrade
Foreign Exchange Rate Adjustments
207.72312.2232.0945.2640.01-39.13
Upgrade
Miscellaneous Cash Flow Adjustments
-20,193---1,893-
Upgrade
Net Cash Flow
3,845-12,9263,013-14,72731,258-2,565
Upgrade
Free Cash Flow
17,352-4,82939,44618,40518,30913,605
Upgrade
Free Cash Flow Growth
--114.32%0.52%34.58%-
Upgrade
Free Cash Flow Margin
2.94%-0.81%7.49%3.84%5.17%4.41%
Upgrade
Free Cash Flow Per Share
809.63-222.961821.12841.34862.87637.47
Upgrade
Cash Interest Paid
6,8496,5134,4213,2301,8581,255
Upgrade
Cash Income Tax Paid
13,7564,8215,2117,5228,92210,086
Upgrade
Levered Free Cash Flow
-11,764-28,2022,59010,19614,8433,209
Upgrade
Unlevered Free Cash Flow
-6,985-22,3865,47412,49816,1423,948
Upgrade
Change in Working Capital
25,109-26,996-4,611-41,027-16,784-14,349
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.